Johnson & Johnson (JNJ) 105.88 $JNJ
Final Glance: Pharmaceuticals companies
AP - 14 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:
Final Glance: Medical Devices companies
AP - 14 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Watch for Johnson & Johnson to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Tue Sep 16, 3:48PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.11%
Comtex SmarTrend(R) - Tue Sep 16, 3:47PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Midday Glance: Pharmaceuticals companies
AP - Tue Sep 16, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Tue Sep 16, 12:22PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
Early Glance: Pharmaceuticals companies
AP - Tue Sep 16, 9:43AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Tue Sep 16, 9:43AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Global Hepatitis C Market Report 2014-2018: Leading Vendors are F. Hoffmann-La Roche, Gilead Sciences, J&J, Merck & Vertex Pharmaceuticals
M2 - Tue Sep 16, 8:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rlbk3z/global_hepatitis) has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. The Global Hepatitis C market to grow at a CAGR of 19.2% over the period 2013-2018 This report covers the present scenario and the growth prospects of the Global Hepatitis C market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through sales of various drugs administered to treat chronic hepatitis caused by genotype 1-6 of hepatitis C virus. One of the emerging trends in the market is the emergence of Interferon -free regimens. Various IFN-free regimens are under development as all-oral regimens. These therapies are expected to attain higher SVR and cause fewer side effects than currently approved therapies. According to the report, the launch of direct-acting antivirals is one of the major drivers of the market. These are administered in combination with other antiviral drugs such as ribavirin and PEG-IFN. They increase the efficacy of treatment and reduce the duration of therapy. Further, the report states that the side effects of current therapies are one of the major challenges in the market. Currently, approved drugs for hepatitis C are associated with poor tolerability and lower patient compliance rates. This, in turn, decreases the market revenue of the currently approved drugs. Key Vendors - F. Hoffmann-La Roche - Gilead Sciences - Johnson & Johnson - Merck - Vertex Pharmaceuticals Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Disease Overview - Market Landscape - Key Marketed Drugs for Treatment of Chronic Hepatitis C - Market Segmentation by MOA - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/rl..._hepatitis
Magpi CEO and Co-founder Dr. Joel Selanikio to Speak at Health Workers Count, Global Health Session Held during the UN General Assembly
PRWeb - Tue Sep 16, 5:13AM CDT
Magpi, a leading provider of configurable, cloud-based mobile data collection and communication applications, today announced that CEO and Co-founder Dr. Joel Selanikio will speak at Health Workers Count, a cross-sector ideation session focusing on the use of technology and big data in global health held in New York City on September 23. Dr. Selanikio will discuss how the social sector can leverage big data to provide insights on global health programming and drive decision-making that enhances the healthcare workforce and health outcomes.
Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org
PRWeb - Mon Sep 15, 2:31PM CDT
"Canada Gynecological Devices Market Outlook to 2020″, provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10483 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/canada-gynecol...-2020.html . Overview of Key Companies in Canada, Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. CooperSurgical, Inc. Cook Group Incorporated Utah Medical Products, Inc. Boston Scientific Corporation Johnson & Johnson Merit Medical Systems, Inc. BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10483 . (This is a premium report priced at US$2500 for a single user License.)
Global Baby Wipe Industry Report 2014
M2 - Mon Sep 15, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbtt7w/global_baby_wipe) has announced the addition of the "Global Baby Wipe Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The baby wipe market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Baby wipe industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on fifteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The baby wipe industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Baby Wipe Industry Overview - Global Baby Wipe Market Status Analysis - Major Regions Baby Wipe Market Status Analysis - Major Countries Baby Wipe Market Status and Analysis - Major Companies Baby Wipe Market Status and Analysis - Baby Wipe Industry Chain and Marketing Channels Analysis - Baby Wipe Industry Segment Market Analysis - Baby Wipe Industry Development Trend - Baby Wipe New Project Investment Feasibility Analysis - Global Baby Wipe Industry Research Conclusions Companies Mentioned - BABISIL (BABISIL) - ELSKER (ELSKER) - FUSTIN - Goodbaby - Hengan (Hearttex) - IVORY - Johnson&Johnson - KIMBERLY-CLARK (HUGGIES) - Les enphants - MAPA (N DENMARK) - PIGEON (PIGEON) - Procter&Gamble(Pampers) - STYLE-USA - Unicharm - UsBaby For more information visit http://www.researchandmarkets.com/research/qb..._baby_wipe
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma
PR Newswire - Mon Sep 15, 8:15AM CDT
Today, Analysts Review released its research reports regarding Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Medtronic, Inc. (NYSE: MDT), Pharmacyclics Inc. (NASDAQ: PCYC) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6464-100free.
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
How to Make Money in Stocks Without Taking Big Risks
Matthew Frankel, The Motley Fool - Motley Fool - Sun Sep 14, 11:02AM CDT
One of the most common financial misconceptions among the American public is assuming the words "stocks" and "risk" are synonymous. Source: flickr This can definitely be true in many cases, and if you invest in stocks without really knowing...
Another Johnson & Johnson Medical Device Recall is Deemed a Class I by Federal Regulators, Parker Waichman LLP Comments
PRWeb - Sun Sep 14, 6:08AM CDT
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured due to medical devices, comments on a recall issued by DePuy Synthes of its Craniomaxillofacial Distraction System. Federal regulators recently deemed the matter a Class I recall, the most serious designation made by the U.S. Food and Drug Administration(FDA). The agency announced the Class I designation on August 28, 2014.
Final Glance: Pharmaceuticals companies
AP - 14 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were up at the close of trading:
Final Glance: Medical Devices companies
AP - 14 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Watch for Johnson & Johnson to Potentially Pullback After Gaining 1.11% Yesterday
Comtex SmarTrend(R) - Tue Sep 16, 3:48PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Johnson & Johnson Set to Possibly Pullback After Yesterday's Rally of 1.11%
Comtex SmarTrend(R) - Tue Sep 16, 3:47PM CDT
Johnson & Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $104.30 to a high of $105.94. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $104.91 on volume of 6.1 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Midday Glance: Pharmaceuticals companies
AP - Tue Sep 16, 12:22PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are up at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Tue Sep 16, 12:22PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Why It's Time for Allergan Shareholders to Take Some Profits
at The Street - Tue Sep 16, 12:09PM CDT
The current dividend does not pay enough for investors to stay.
Early Glance: Pharmaceuticals companies
AP - Tue Sep 16, 9:43AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Early Glance: Medical Devices companies
AP - Tue Sep 16, 9:43AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Global Hepatitis C Market Report 2014-2018: Leading Vendors are F. Hoffmann-La Roche, Gilead Sciences, J&J, Merck & Vertex Pharmaceuticals
M2 - Tue Sep 16, 8:15AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rlbk3z/global_hepatitis) has announced the addition of the "Global Hepatitis C Market 2014-2018" report to their offering. The Global Hepatitis C market to grow at a CAGR of 19.2% over the period 2013-2018 This report covers the present scenario and the growth prospects of the Global Hepatitis C market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through sales of various drugs administered to treat chronic hepatitis caused by genotype 1-6 of hepatitis C virus. One of the emerging trends in the market is the emergence of Interferon -free regimens. Various IFN-free regimens are under development as all-oral regimens. These therapies are expected to attain higher SVR and cause fewer side effects than currently approved therapies. According to the report, the launch of direct-acting antivirals is one of the major drivers of the market. These are administered in combination with other antiviral drugs such as ribavirin and PEG-IFN. They increase the efficacy of treatment and reduce the duration of therapy. Further, the report states that the side effects of current therapies are one of the major challenges in the market. Currently, approved drugs for hepatitis C are associated with poor tolerability and lower patient compliance rates. This, in turn, decreases the market revenue of the currently approved drugs. Key Vendors - F. Hoffmann-La Roche - Gilead Sciences - Johnson & Johnson - Merck - Vertex Pharmaceuticals Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Disease Overview - Market Landscape - Key Marketed Drugs for Treatment of Chronic Hepatitis C - Market Segmentation by MOA - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/rl..._hepatitis
Magpi CEO and Co-founder Dr. Joel Selanikio to Speak at Health Workers Count, Global Health Session Held during the UN General Assembly
PRWeb - Tue Sep 16, 5:13AM CDT
Magpi, a leading provider of configurable, cloud-based mobile data collection and communication applications, today announced that CEO and Co-founder Dr. Joel Selanikio will speak at Health Workers Count, a cross-sector ideation session focusing on the use of technology and big data in global health held in New York City on September 23. Dr. Selanikio will discuss how the social sector can leverage big data to provide insights on global health programming and drive decision-making that enhances the healthcare workforce and health outcomes.
Canada Gynecological Devices Market Outlook to 2020 in New Report Available at MarketOptimizer.org
PRWeb - Mon Sep 15, 2:31PM CDT
"Canada Gynecological Devices Market Outlook to 2020″, provides key market data on the Canada Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings) Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge) The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Gynecological Devices market wherever available. Order a Purchase Copy @ http://www.marketoptimizer.org/contacts/purchase?rname=10483 . The data in the report is derived from dynamic market forecast models. Epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Complete Report Details Available @ http://www.marketoptimizer.org/canada-gynecol...-2020.html . Overview of Key Companies in Canada, Gynecological Devices Market: Conceptus, Inc. Hologic, Inc. CooperSurgical, Inc. Cook Group Incorporated Utah Medical Products, Inc. Boston Scientific Corporation Johnson & Johnson Merit Medical Systems, Inc. BSD Medical Corporation Scope Market size data for Gynecological Devices market segments - Female Sterilization Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization Devices (Tubal Clips and Rings)), Endometrial Ablation Devices (Thermal Balloon, Hydrothermal Ablation (HTA), Bipolar Energy, Cryotherapy and Microwave Endometrial Ablation Devices) and Uterine Fibroid Embolization Agents (Poly Vinyl Alcohol Particles, Trisacryl Gelatin Microspheres and Gelatin Sponge). Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. 2013 company shares and distribution shares data for Gynecological Devices market. Global corporate-level profiles of key companies operating within the Gynecological Devices market. Key players covered include Bayer Healthcare, Hologic, Boston Scientific, Microsulis Medical Limited, Cook Medical and Merit Medical. Reasons to buy Develop business strategies by identifying the key market categories and segments poised for strong growth in the future. Develop market-entry and market expansion strategies. Design competition strategies by identifying who-stands-where in the market. Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize. Inquire before Buying @ http://www.marketoptimizer.org/contacts/inqui...name=10483 . (This is a premium report priced at US$2500 for a single user License.)
Global Baby Wipe Industry Report 2014
M2 - Mon Sep 15, 10:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qbtt7w/global_baby_wipe) has announced the addition of the "Global Baby Wipe Industry Report 2014" report to their offering. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The baby wipe market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are also discussed and manufacturing processes and cost structures analyzed. Baby wipe industry import/export consumption, supply and demand figures and cost price and production value gross margins are also provided. The report focuses on fifteen industry players providing information such as company profiles, product picture and specification, capacity production, price, cost, production value and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The baby wipe industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. Key Topics Covered: - Baby Wipe Industry Overview - Global Baby Wipe Market Status Analysis - Major Regions Baby Wipe Market Status Analysis - Major Countries Baby Wipe Market Status and Analysis - Major Companies Baby Wipe Market Status and Analysis - Baby Wipe Industry Chain and Marketing Channels Analysis - Baby Wipe Industry Segment Market Analysis - Baby Wipe Industry Development Trend - Baby Wipe New Project Investment Feasibility Analysis - Global Baby Wipe Industry Research Conclusions Companies Mentioned - BABISIL (BABISIL) - ELSKER (ELSKER) - FUSTIN - Goodbaby - Hengan (Hearttex) - IVORY - Johnson&Johnson - KIMBERLY-CLARK (HUGGIES) - Les enphants - MAPA (N DENMARK) - PIGEON (PIGEON) - Procter&Gamble(Pampers) - STYLE-USA - Unicharm - UsBaby For more information visit http://www.researchandmarkets.com/research/qb..._baby_wipe
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma
PR Newswire - Mon Sep 15, 8:15AM CDT
Today, Analysts Review released its research reports regarding Johnson & Johnson (NYSE: JNJ), Merck & Co. Inc. (NYSE: MRK), Medtronic, Inc. (NYSE: MDT), Pharmacyclics Inc. (NASDAQ: PCYC) and NPS Pharmaceuticals, Inc. (NASDAQ: NPSP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6464-100free.
Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade - 2014 Report for the $42 Billion Industry
M2 - Mon Sep 15, 6:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hmf95l/surgical) has announced the addition of Supplier Relations US, LLC's new report "Surgical Appliance and Supplies Manufacturing Industry in the U.S. and its International Trade [2014 Q3 Edition]" to their offering. The Surgical Appliance and Supplies Manufacturing Industry report contains the most recent data and analysis on the industry's key financial data, cost and pricing, competitive landscape, industry structure. Also updated are the latest trade, shipment, and inventory data available through July 2014. This update provides the data necessary to make informed forecasts and business planning after the recent seasonal changes in output. The industry's revenue for the year 2013 was reported at $42.3 billion USD, with an estimated gross profit of 44.21%. Import was valued at $12.5 billion USD from 91 countries. The industry also exported $8.8 billion USD worth of merchandise to 199 countries. Adding import value to and subtracting export value from the industry's shipment value, the total domestic demand for the industry in 2013 was $46.0 billion USD. In this report, you will find industry data on the following major categories: - Executive Summary - Industry Income Statement - Industry Balance Sheet - Capital Expenditure - Industry Cost Analysis - Industry Pricing Analysis - Industry Foreign Trade - Industry Structure - Competitive Landscape Companies Mentioned - Baxter International Inc. - Becton, Dickinson & Company - Boston Scientific Corporation - Cardinal Health, Inc. - Cooper Companies Inc. - Covidien - Edwards Lifesciences Corporation - Hill-Rom - Intuitive Surgical, Inc. - Invacare Corporation - Johnson & Johnson - Kimberly-Clark Corporation - Kinetic Concepts, Inc. - Medtronic, Inc. - Mine Safety Appliances Company - Pall Corporation - Royal Philips Electronics - St. Jude Medical, Inc. - STERIS Corporation - Stryker Corporation - Synthes North America - Teleflex Incorporated - West Pharmaceutical Services, Inc. - Wright Medical Group, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/hmf95l/surgical Source: Supplier Relations US, LLC
How to Make Money in Stocks Without Taking Big Risks
Matthew Frankel, The Motley Fool - Motley Fool - Sun Sep 14, 11:02AM CDT
One of the most common financial misconceptions among the American public is assuming the words "stocks" and "risk" are synonymous. Source: flickr This can definitely be true in many cases, and if you invest in stocks without really knowing...
Another Johnson & Johnson Medical Device Recall is Deemed a Class I by Federal Regulators, Parker Waichman LLP Comments
PRWeb - Sun Sep 14, 6:08AM CDT
Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been injured due to medical devices, comments on a recall issued by DePuy Synthes of its Craniomaxillofacial Distraction System. Federal regulators recently deemed the matter a Class I recall, the most serious designation made by the U.S. Food and Drug Administration(FDA). The agency announced the Class I designation on August 28, 2014.
